Artivion, Inc.
General ticker "AORT" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $1.8B (TTM average)
Artivion, Inc. does not follow the US Stock Market performance with the rate: -38.5%.
Estimated limits based on current volatility of 2.1%: low 21.32$, high 22.25$
Factors to consider:
- Total employees count: 1800 (+12.5%) as of 2025
- US accounted for 48.5% of revenue in the fiscal year ended 2025-12-31
- Top business risk factors: Geopolitical risks, Market competition, Operational and conduct risks, Supply chain disruptions, Regulatory and compliance
- Current price 29.7% below estimated low
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [30.96$, 52.38$]
- 2026-12-31 to 2027-12-31 estimated range: [28.47$, 49.45$]
Financial Metrics affecting the AORT estimates:
- Positive: with PPE of 200.8 at the end of fiscal year the price was neutral
- Negative: Operating cash flow per share per price, % of 1.89 <= 2.37
- Positive: 4.60 < Operating profit margin, % of 7.53
- Positive: 0.90 < Return on assets ratio (scaled to [-100,100]) of 1.09
- Positive: Inventory ratio change, % of 0.06 <= 0.41
- Negative: 49.86 < Shareholder equity ratio, % of 50.66 <= 58.56
- Positive: -2.60 < Investing cash flow per share per price, % of -2.00
Short-term AORT quotes
Long-term AORT plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $354.00MM | $388.54MM | $448.33MM |
| Operating Expenses | $348.26MM | $349.66MM | $414.58MM |
| Operating Income | $5.74MM | $38.87MM | $33.74MM |
| Non-Operating Income | $-27.33MM | $-46.39MM | $-18.96MM |
| Interest Expense | $25.30MM | $34.28MM | $26.58MM |
| R&D Expense | $28.71MM | $28.45MM | $30.99MM |
| Income(Loss) | $-21.59MM | $-7.51MM | $14.78MM |
| Taxes | $9.10MM | $5.84MM | $5.01MM |
| Net Income(Loss)* | $-30.69MM | $-13.36MM | $9.77MM |
| Stockholders Equity | $281.78MM | $276.20MM | $448.23MM |
| Inventory | $81.98MM | $79.77MM | $92.43MM |
| Assets | $792.40MM | $789.10MM | $884.80MM |
| Operating Cash Flow | $18.82MM | $22.24MM | $39.88MM |
| Capital expenditure | $7.43MM | $11.19MM | $39.04MM |
| Investing Cash Flow | $-0.50MM | $-28.19MM | $-42.04MM |
| Financing Cash Flow | $0.86MM | $2.20MM | $11.28MM |
| Earnings Per Share** | $-0.75 | $-0.32 | $0.22 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.